Susanne Gawenda

Title: Susanne Gawenda: Innovator in Enzyme Immobilization

Introduction

Susanne Gawenda is a notable inventor based in Birkenau, Germany. She has made significant contributions to the field of enzyme immobilization, particularly through her innovative patent. Her work has implications for medical diagnostics, especially in the context of diseases such as diabetes.

Latest Patents

Susanne Gawenda holds a patent for "High load enzyme immobilization by crosslinking." This patent describes methods of cross-linking polypeptide molecules by combining a cross-linking agent and polypeptide molecules in a solution under suitable conditions for a cross-linking reaction. The patent also details preparations of cross-linked polypeptide molecules, which are cross-linked by essentially unbranched cross-linking groups of at least 40 contiguous atoms. Additionally, it provides test chemistry matrices and methods for creating them, which include a redox cofactor and an indicator reagent. These innovations are particularly useful for diagnosing diseases, including diabetes.

Career Highlights

Throughout her career, Susanne has worked with prominent companies in the healthcare sector. She has been associated with Roche Diabetes Care, Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to advancements in diabetes care.

Collaborations

One of her notable collaborators is Carina Horn. Their partnership has likely fostered further innovation in their respective fields.

Conclusion

Susanne Gawenda's contributions to enzyme immobilization and her innovative patent highlight her role as a significant inventor in the medical diagnostics field. Her work continues to influence advancements in healthcare, particularly in the management of diabetes.